Inmune Bio Inc.
INMB· Nasdaq
Released Mar 10, 2020, after the close
10-K filed Mar 11, 2020, 71 days after period end · 0001213900-20-005916
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|
| Net Income | -$2.32M | -$1.88M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inmune Bio Inc. · CIK 1711754 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 11, 2020 · 71 d after period end
10.8% from the close of Mar 9, 2020 to the close of Mar 12, 2020, the first after the release.